1. Anon Hepatic toxicity possibly associated with kava-containing products — United States, Germany, and Switzerland, 1999–2002;MMWR,2002
2. AkdÄ — Arzneimittelkommission der deutschen Ärzteschaft Evidenzbasierte Therapieleitlinien — Angst- und Zwangsstörungen,2002
3. Pharmacology of recombinant gamma-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated alpha-subunits;Benson;FEBS Lett,1998
4. BfArM, Widerruf der Zulassung von Kava-Präparaten14.6.2002 http://www.bfarm.de/de_ver/arzneimittel/amrisiken/stufenplan/Besch-Kava-Final.pdf
5. Kava-kava and anxiety: growing knowledge about the efficacy and safety;Bilia;Life Sci,2002